Company Epigenomics AG Deutsche Boerse AG

Equities

ECX

DE000A11QW50

Biotechnology & Medical Research

End-of-day quote Deutsche Boerse AG 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
1.785 EUR -1.92% Intraday chart for Epigenomics AG +9.51% -4.03%

Business Summary

Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.

Sales per Business

EUR in Million2021Weight2022Weight Delta
In Vitro Diagnostic - Products
95.9 %
0 7.5 % 0 95.9 % -.--%
Licensing
4.1 %
0 0.4 % 0 4.1 % -9.09%

Sales per region

EUR in Million2021Weight2022Weight Delta
North America
54.2 %
0 4.8 % 0 54.2 % -11.45%
Europe
38.6 %
0 3.0 % 0 38.6 % -1.06%
Asia
7.2 %
6 92.2 % 0 7.2 % -99.39%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 866,351 575,540 ( 66.43 %) 0 66.43 %

Shareholders

NameEquities%Valuation
LBBW Asset Management Investmentgesellschaft mbH
0.4793 %
818 0.4793 % 1 660 €
Decalia Asset Management SIM SpA
0.3369 %
575 0.3369 % 1 167 €
Hauck & Aufhäuser Investment Gesellschaft SA
0.3146 %
537 0.3146 % 1 090 €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2250 %
384 0.2250 % 779 €
Union Investment Privatfonds GmbH
0.1260 %
215 0.1260 % 436 €
HSBC Global Asset Management (Deutschland) GmbH
0.1172 %
200 0.1172 % 406 €
Union Investment Institutional GmbH
0.0633 %
108 0.0633 % 219 €
Pioneer Investments Austria GmbH
0.0545 %
93 0.0545 % 189 €
Cominvest Asset Management GmbH
0.0516 %
88 0.0516 % 179 €
BayernInvest Kapitalverwaltungsgesellschaft mbH
0.0135 %
23 0.0135 % 47 €

Company contact information

Epigenomics AG

Bertha-Benz-Strasse 5

10557, Berlin

+49 30 243 450

http://www.epigenomics.com/de/
address Epigenomics AG(ECX)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.86 EUR
Average target price
16.85 EUR
Spread / Average Target
+805.91%
Consensus

Annual profits - Rate of surprise